ロード中...
Opioid abusers’ ability to differentiate an opioid from placebo in laboratory challenge testing()
BACKGROUND: Abuse liability assessments influence drug development, federal regulation, and clinical care. One suggested procedure to reduce variability of assessments is a qualification phase, which assesses whether study applicants adequately distinguish active drug from placebo; applicants failin...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3911782/ https://ncbi.nlm.nih.gov/pubmed/23369645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.01.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|